非心脏手术多模式镇痛组合的工具变量分析
该研究基于6家退伍军人健康管理局医院2017至2022年23 238例择期非心脏全麻手术,以麻醉医师为工具变量分析多模式镇痛(MMA)效果。住院患者使用MMA术后口服吗啡当量减少6.8(95%CI -10.2至-3.4),门诊患者疼痛评分平均降低1.0(95%CI -1.6至-0.4)。非甾体抗炎药联合地塞米松或区域麻醉对阿片用量降幅最大。
要点
- MMA可减少非心脏手术术后阿片用量及疼痛评分
- NSAIDs联合地塞米松或区域麻醉对阿片用量降幅最大
- 对乙酰氨基酚虽普遍使用但非最优组合成分
核心结论
- MMA可有效减少非心脏手术术后疼痛和阿片用量,地塞米松与NSAIDs而非对乙酰氨基酚带来最大获益。
研究设计与样本
- 采用工具变量分析,以麻醉医师为工具变量模拟随机分配至特定镇痛药物组合。
主要发现
- 23 238例手术中46.1%接受MMA,MMA在年轻、女性及死亡概率较低患者中更常见。
- 住院患者接受MMA术后阿片用量减少6.8个口服吗啡当量(95%CI -10.2至-3.4)。
- 门诊患者接受MMA术后疼痛评分平均降低1.0个单位(95%CI -1.6至-0.4)。
- NSAIDs联合地塞米松阿片用量平均减少29.5个口服吗啡当量(95%CI -36.9至-19.5)。
- NSAIDs联合区域麻醉阿片用量平均减少28.4个口服吗啡当量(95%CI -40.1至-16.8)。
临床怎么用
- 非心脏手术围术期MMA方案中应优先考虑NSAIDs联合地塞米松或区域麻醉。
- 不应默认将对乙酰氨基酚作为MMA核心成分,需进一步研究其独立效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimodal analgesia (MMA) is a perioperative pain management strategy that targets various pain pathways, resulting in reduced postoperative pain and opioid use. Unfortunately, the optimal combinations of pain medications to use with perioperative MMA remain uncertain. Our goal was to estimate the treatment effect of MMA on postoperative pain and opioid use and identify optimal non-opioid medication combinations to enhance MMA benefits. METHODS: The study population includes all patients undergoing elective non-cardiac surgery with general anesthesia between 1 January 2017 and 31 December 2022 at six geographically similar Veterans Health Administration hospitals. An instrumental variable (IV) analysis was conducted using the anesthesiologist as the instrument to emulate randomization to receiving specific pain medication combinations. Outcomes were self-reported pain and opioid use after surgery. RESULTS: Of the 23 238 procedures included in the study, 46.1% received MMA. MMA was more common in younger patients, females and those with a lower probability of mortality. With IV analysis, inpatients with MMA required 6.8 fewer oral morphine equivalents (OMEs, 95% CI -10.2, to -3.4) in the postoperative period, and outpatients with MMA reported postoperative pain scores that were, on average, 1.0 unit lower than patients who did not receive MMA (95% CI -1.6 to -0.4). Combinations of non-steroidal anti-inflammatory drugs (NSAIDs) plus dexamethasone or regional anesthesia resulted in the greatest reductions in postoperative opioid use (mean reduction -29.5 OMEs, 95% CI -36.9 to -19.5 and mean reduction -28.4 OMEs, 95% CI -40.1 to -16.8, respectively). CONCLUSION: Our findings further support existing evidence on the effectiveness of MMA in reducing postoperative pain and opioid use following non-cardiac surgery. Importantly, our study highlights that dexamethasone and NSAIDs, not acetaminophen, which is almost universally used in MMA regimens, resulted in the greatest reduction of postoperative pain and postoperative opioid use. This has significant implications for the continued use of NSAIDs and dexamethasone in MMA protocols and underscores the need for future studies exploring the independent effect of intravenous acetaminophen on postoperative pain.
引用
- Graham LA, Illarmo S, Wren SM, et al. Optimal multimodal analgesia combinations to reduce pain and opioid use following non-cardiac surgery: an instrumental variable analysis. Reg Anesth Pain Med. 2025. PMID: 40659442. doi:10.1136/rapm-2025-106720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。